NCT02657265

Brief Summary

This study will compare two standard treatments in acute stable traumatic vertebral fractures (types A1 and A3.1 by Magerl Classification). The two treatments are as follows:

  1. 1.SpineJack® system
  2. 2.Conservative Orthopedic Management consisting of brace and pain medication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2016

Completed
8 days until next milestone

Study Start

First participant enrolled

January 13, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 15, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2019

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2020

Completed
Last Updated

April 20, 2023

Status Verified

April 1, 2023

Enrollment Period

3.4 years

First QC Date

January 5, 2016

Last Update Submit

April 17, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • VAS

    Mean Visual Analogue Scale (VAS) back pain score at 1 and 12 months follow-up

    1 and 12 months follow-up

Secondary Outcomes (6)

  • Oswestry Disability Index

    Screening/baseline, immediat post-op, 1, 3, 12 and 24 months

  • EQ-5D

    Screening/baseline, immediat post-op, 1, 3, 12 and 24 months

  • Kyphotic angle

    Screening/baseline, immediat post-op, 1, 3, 12 and 24 months

  • Regional Kyphotic Angle

    Screening/baseline, immediat post-op, 1, 3, 12 and 24 months

  • Evaluation of safety through evaluation of adverse events

    Screening/baseline, immediat post-op, 1, 3, 12 and 24 months

  • +1 more secondary outcomes

Study Arms (2)

SpineJack® system

EXPERIMENTAL

Spine fracture management

Device: SpineJack system

Conservative management

ACTIVE COMPARATOR

Surgical corset according to measurement's impression, rigid corset with sternal support

Device: Conservative management

Interventions

Spine fracture management for traumatic vertebral compression fracture

SpineJack® system

Surgical corset according to measurement's impression, rigid corset with sternal support

Conservative management

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient must have signed the consent form
  • Male or Female between 18 and 60 years old
  • Vertebral kyphosis angle \>10°
  • Patient is eligible to treatment with brace
  • Technical feasibility of a SpineJack® procedure and brace 1 to 5 days after screening/baseline

You may not qualify if:

  • Vertebral fracture more than 10 days old
  • Spontaneous osteoporotic vertebral fracture
  • Neurological signs or symptoms related to the vertebral fracture
  • Vertebral kyphosis angle \>30°
  • Active systemic or local infection at baseline
  • Patient with substance abuse
  • History of intolerance or allergic reaction to titanium or acrylic compounds
  • Fracture geometry making the insertion of the implant impossible
  • Malignant lesions
  • Any other medical illness or condition that, in the investigator's opinion, is likely to impair long-term follow-up (e.g., cancer) or greatly increase the risk of surgery\*
  • Patient on long-term steroid therapy (steroid dose ≥ 30 mg /day for \> 3 months)
  • Patient presenting with a non-correctable spontaneous or therapeutic coagulation disorder.
  • Non-compliant patient: Impossibility to participate in the study and to be followed-up for 2 years.
  • Participating in any other investigational study
  • Female patients who are pregnant, breastfeeding, or planning to get pregnant during the course of the study
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Hopital Jean Minjoz Besancon

Besançon, France

Location

CHU de Bordeaux - Hopital Pellegrin

Bordeaux, France

Location

CHU Brest

Brest, France

Location

Centre Hospitalier De Chambéry

Chambéry, France

Location

CHU de Dijon

Dijon, France

Location

APHM, Hopital Nord Marseille

Marseille, France

Location

CHU de Rennes

Rennes, France

Location

CHU de Rouen-Hopital Charles Nicolle

Rouen, France

Location

Centre Hospitalier Privé Saint Grégoire

Saint-Grégoire, France

Location

Related Publications (1)

  • Ould-Slimane M, Petit A, Gille O, Kaya JM, Touta A, Lebhar J, Grelat M. A prospective multicenter randomized study comparing the SpineJack system and nonsurgical management with a brace in acute traumatic vertebral fractures: the SPICO study. J Neurosurg Spine. 2024 Mar 1;40(6):790-800. doi: 10.3171/2023.12.SPINE23824. Print 2024 Jun 1.

MeSH Terms

Conditions

Spinal FracturesBack InjuriesWounds and Injuries

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Spinal InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Jean-Marc Vital, Prof.

    Hopital Pellegrin - Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 5, 2016

First Posted

January 15, 2016

Study Start

January 13, 2016

Primary Completion

May 27, 2019

Study Completion

May 25, 2020

Last Updated

April 20, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations